Home › NDC Lookup › RxCUI directory › RxCUI 2711556

24 HR diazoxide choline 150 MG Extended Release Oral Tablet [Vykat] — RxCUI 2711556

RxNorm drug concept · Semantic branded drug
RxCUI 2711556 Semantic branded drug · SBD ● Current RxNorm concept 3 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2711556
Official name24 HR diazoxide choline 150 MG Extended Release Oral Tablet [Vykat]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asVykat XR 150 MG 24 HR Extended Release Oral Tablet; vykat XR 150 MG 24HR Extended Release Oral Tablet
FDA products mapped3
Package NDCs mapped3
Reported Medicaid activity (SDUD)1,026 prescriptions · 17 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How 24 HR diazoxide choline 150 MG Extended Release... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 24 HR diazoxide choline 150 MG Extended Release Oral Tablet [Vykat] RxCUI 2711556

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Diazoxide 3327
    • Diazoxide choline 2711542
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Vykat 2711550
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Diazoxide Extended Release Oral Tablet 2711544
    • Diazoxide choline Extended Release Oral Tablet 2711547
    • Diazoxide Oral Product 1155867
    • Diazoxide Pill 1155868
    • Diazoxide choline Oral Product 2711545
    • Diazoxide choline Pill 2711546
    • Diazoxide Extended Release Oral Tablet [Vykat] 2711554
    • Diazoxide choline Extended Release Oral Tablet [Vykat] 2711555
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • 24 HR diazoxide choline 150 MG Extended Release Oral Tablet SCD · 2711548
  • Diazoxide choline 150 MG SCDC · 2711543
  • Diazoxide Extended Release Oral Tablet SCDF · 2711544
  • Diazoxide choline Extended Release Oral Tablet SCDFP · 2711547
  • Diazoxide Oral Product SCDG · 1155867
  • Diazoxide Pill SCDG · 1155868
  • Diazoxide choline Oral Product SCDGP · 2711545
  • Diazoxide choline Pill SCDGP · 2711546

Brand-Name Concepts

  • Diazoxide choline 150 MG [Vykat] SBDC · 2711551
  • Diazoxide Extended Release Oral Tablet [Vykat] SBDF · 2711554
  • Diazoxide choline Extended Release Oral Tablet [Vykat] SBDFP · 2711555
  • Vykat Oral Product SBDG · 2711552
  • Vykat Pill SBDG · 2711553
  • Vykat BN · 2711550

📦 FDA Products & Package NDCs

3 products · 3 package NDCs
3 package NDCs map to RxCUI 2711556 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
83860-0025-01 30 TABLET, FILM COATED in 1 BOTTLE (83860-025-01) VYKAT XR Soleno Therapeutics, Inc. 2025-03-26
83860-0075-01 30 TABLET, FILM COATED in 1 BOTTLE (83860-075-01) VYKAT XR Soleno Therapeutics, Inc. 2025-03-26
83860-0150-01 30 TABLET, FILM COATED in 1 BOTTLE (83860-150-01) VYKAT XR Soleno Therapeutics, Inc. 2025-03-26
Observed labelers: Soleno Therapeutics, Inc. (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.